RxDoctor Payments DataLook up a doctor →

Clark Larsen, DPM

Podiatrist · Murray, UTNPI 1427130335

Payments from drug & device makers

$1,178,911in general payments, 2019–2025

Across 380 payments — averaging $3102.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$987K
  • Endo Pharmaceuticals Inc.$124K
  • Lexicon Pharmaceuticals, Inc.$33K
  • Axogen$19K
  • Bioventus LLC$11K
  • Zyla Life Sciences, Inc.$972
  • plus $4K from 46 others
$37,197in research payments, 2019–2025

Across 4 payments — averaging $9299.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Integra Lifesciences Corporation$37K

What the payments were for

  • Consulting fees$4253%
  • Speaking & faculty fees$9,61259%
  • Travel & lodging$9196%
  • Food & beverage$5,29733%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,178,911 in reported general payments places this provider in the 95th percentile of 59 podiatrist providers in Utah.

See all podiatrist providers in Utah

Medicare billing

Part B allowed, 2024
$172,067
Medicare patients
322
Services billed
2,554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin53$559
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen51$478
Gabapentin22$258
Ondansetron Hcl39$246
Methylprednisolone19$180
Allopurinol20$99
Tramadol Hcl26$86
Meloxicam19$68

Paid to pharmacies, not to this prescriber.

Other podiatrist in Murray

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →